Detalhe da pesquisa
1.
STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway.
Mol Cancer
; 22(1): 133, 2023 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37573301
2.
Bone marrow microenvironment- induced regulation of Bcl-2 family members in multiple myeloma (MM): Therapeutic implications.
Cytokine
; 161: 156062, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332463
3.
Thyroid and androgen receptor signaling are antagonized by µ-Crystallin in prostate cancer.
Int J Cancer
; 148(3): 731-747, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33034050
4.
Serum ß-Defensin-2 Levels and Their Relationship with the Clinical Course and Prognosis in Patients with Crimean-Congo Hemorrhagic Fever.
Med Princ Pract
; 25(2): 163-8, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26539993
5.
Favorable impact of PD1/PD-L1 antagonists on bone remodeling: an exploratory prospective clinical study and ex vivo validation.
J Immunother Cancer
; 12(5)2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38702145
6.
Emerging role of T3-binding protein µ-crystallin (CRYM) in health and disease.
Trends Endocrinol Metab
; 33(12): 804-816, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36344381
7.
On the continuous (R)evolution of antibody-based and CAR T cell therapies in multiple myeloma: an early 2022 glance into the future.
Expert Opin Pharmacother
; 23(12): 1425-1444, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35829636
8.
STAT3 regulated ARF expression suppresses prostate cancer metastasis.
Nat Commun
; 6: 7736, 2015 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-26198641
9.
Erratum: STAT3 regulated ARF expression suppresses prostate cancer metastasis.
Nat Commun
; 6: 8802, 2015 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26499136